Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes

The summary for the Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes: Over 5 million adults in the U.S. have undiagnosed type 2 diabetes, and another 38 million with pre-diabetes are at increased risk for developing diabetes. The lack of a simple and reliable way to detect diabetes and pre- diabetes has hindered identification of these individuals and provision of effective therapies. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) encourages the application of proteomic and other novel technology to develop new diagnostic tests and/or to identify new biomarkers for the diagnosis of pre-diabetes and/or diabetes that do not require fasting or glucose administration.
Federal Grant Title: Proteomic and Metabolomic Approaches to Diagnose Diabetes and Pre-Diabetes
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-04-076
Type of Funding: Grant
CFDA Numbers: 93.847
CFDA Descriptions: Diabetes, Endocrinology and Metabolism Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Mar 23, 2004
Creation Date: Aug 20, 2004
Archive Date: Aug 20, 2004
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster FBOWebmaster@OD.NIH.GOV NIH OER Webmaster
Similar Government Grants
High Priority HIV/AIDS Research within the Mission of the NIDDK (R01 Clinical Trial Option...
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell R...
Development and Integration of Novel Components for Open and Closed Loop Hormone Replaceme...
Elucidating the Effect of Glycemic Excursions on Patient Well-being and Cognitive Status i...
Clinical, Behavioral and Physiological Research Testing Current and Novel Closed Loop Syst...
Molecular Therapy Core Centers
Pilot and Feasibility Program in Human Islet Biology
Diabetes Endocrinology Research Centers
More Grants from the National Institutes of Health
Coordinating Center to Support NIDA Rural Opioid HIV and Comorbidity Initiative (U24 - Cli...
Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Developm...
Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clini...
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinica...
Genomic Centers for Infectious Diseases (U19 Clinical Trial Not Allowed) is not endorsed by, or affiliated with, any government agency. Copyright ©2018